Henry Schein, Inc. $HSIC Shares Sold by Blair William & Co. IL

Blair William & Co. IL cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 5.8% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,665 shares of the company’s stock after selling 529 shares during the period. Blair William & Co. IL’s holdings in Henry Schein were worth $633,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Alliancebernstein L.P. lifted its stake in Henry Schein by 21.9% during the first quarter. Alliancebernstein L.P. now owns 218,340 shares of the company’s stock valued at $14,954,000 after purchasing an additional 39,188 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company’s stock valued at $186,000 after purchasing an additional 1,898 shares during the last quarter. Great Lakes Advisors LLC acquired a new stake in Henry Schein during the first quarter valued at approximately $4,477,000. State of Alaska Department of Revenue lifted its stake in Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company’s stock valued at $1,000,000 after purchasing an additional 395 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its stake in Henry Schein by 5.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company’s stock valued at $941,000 after purchasing an additional 678 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Price Performance

NASDAQ HSIC opened at $62.03 on Friday. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a fifty day simple moving average of $67.18 and a 200 day simple moving average of $68.64. The company has a market cap of $7.52 billion, a P/E ratio of 20.01, a P/E/G ratio of 2.09 and a beta of 0.81. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein’s revenue for the quarter was up 3.3% on a year-over-year basis. During the same period last year, the company earned $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. Leerink Partners set a $75.00 target price on shares of Henry Schein in a research note on Monday, July 14th. Evercore ISI upgraded shares of Henry Schein from an “in-line” rating to an “outperform” rating and set a $83.00 price target for the company in a research report on Tuesday, August 26th. Barrington Research restated an “outperform” rating and issued a $78.00 price target on shares of Henry Schein in a research report on Tuesday, September 23rd. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating for the company in a research report on Wednesday, August 6th. Finally, Wall Street Zen downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Saturday, October 11th. Five analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $76.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.